Login / Signup
PD-1 inhibitor combined with SBRT, GM-CSF, and thymosin alpha-1 in metastatic breast cancer: A case report and literature review.
Jiamin Yu
Qiang Wang
Lijun Wang
Dan Zong
Xia He
Published in:
Medicine (2024)
This treatment regimen may offer a promising treatment strategy for patients with mTNBC and other metastatic solid cancers.
Keyphrases
</>
metastatic breast cancer
small cell lung cancer
radiation therapy
combination therapy
replacement therapy